Spinal Cord Injury Registry - North American Clinical Trials Network

Part of paid clinical trials in Miami, Florida.

Sponsor
Robert G. Grossman, MD
Study ID
NCT00178724
Status
Recruiting

Conditions

  • Spinal Cord Injury

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No Treatment Given — OTHER
    Intervention is not given.

Study Details

The NACTN Spinal Cord Injury Registry is a network of clinical centers collecting de-identified data from patients admitted through the Emergency Department of a NACTN center at the time of injury with an initial (first time) spinal cord injury (SCI). Information will be collected on the natural history of SCI and course of treatment through the first 12 months from the date of injury or long as medically indicated. Data collected includes imaging information from CT or MRI scans, neurological and general medical outcome and rehabilitation evaluation. No intervention is given other than standard of care for spinal cord injury, intensive monitoring and frequent follow up care.

Key Dates

Start date
Jul 31, 2005
Status verified
Sep 2020
Primary completion
Jul 31, 2025
Completion
Jul 31, 2028

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: No Treatment Given
    Any male or female 18 years or older admitted to a NACTN hospital, at the time of injury, with an initial (first time) spinal cord injury caused by trauma and has paralysis (muscle weakness) or loss of sensation (touch). The patient has not received medical or surgical care for this injury prior to admission to a NACTN hospital. Patient or family member must give consent to participate.

Primary Outcome Measure

International Standards For Neurological Classification of Spinal Injury (ISNCSCI) [ Time Frame: Pre-operative, Post-operative, 2 weeks, Discharge, 3 months, 6 months, 12 months, 36 months and 48 months ]

Central Contacts

  • Elizabeth G Toups, MSN, RN, CCRP
    832-722-4055
  • Tanisha Bernhardt
    713-441-3814

Locations (13)

FacilityCityStateZIPSite coordinators
University of MiamiMiamiFlorida33136
George Jimsheleishvihi, MD
305-243-4781
James D Guest, MD, PhD (PRINCIPAL_INVESTIGATOR)
University of Louisville Health Sciences CenterLouisvilleKentucky40205-
Louisiana State University Medical Sciences Center in New OrleansNew OrleansLouisiana70112
Jason D Wilson, MD (PRINCIPAL_INVESTIGATOR)
University of Maryland Medical CenterBaltimoreMaryland21201
Kaitlyn Henry
410-328-0756
Bizhan Aarabi, MD (PRINCIPAL_INVESTIGATOR)
Walter Reed National Military Medical CenterBethesdaMaryland20889
Nadia Ouedraogo
301-319-0269
Christopher J Neal, MD (PRINCIPAL_INVESTIGATOR)
Duke UniversityDurhamNorth Carolina27710
Karen L Grace, BSN
919-613-3801
Christopher I Shaffrey, MD (PRINCIPAL_INVESTIGATOR)
Muhammad Abd-El-Barr, MD, PhD (SUB_INVESTIGATOR)
Thomas Jefferson UniversityPhiladelphiaPennsylvania19107
Sara Thalheimer
215-503-9110
James S Harrop, MD (PRINCIPAL_INVESTIGATOR)
Hamid Shah, MDNashvilleTennessee37240
Melba Isom
615-875-5853
Hamid Shah, MD (PRINCIPAL_INVESTIGATOR)
Brooke Army Medical CenterFort Sam HoustonTexas78234-
Houston Methodist HospitalHoustonTexas77030-
The University of Texas, HoustonHoustonTexas77030
Lisa Schmitt, MS RN
713-327-0116
Karl Schmitt, MD (PRINCIPAL_INVESTIGATOR)
University of Virginia Health SystemCharlottesvilleVirginia22903
Judy Beenhakker, MS
434-982-1856
Chun-Po Yen, MD (PRINCIPAL_INVESTIGATOR)
Medical College of WisconsinMilwaukeeWisconsin53226
Sarah Cornell, BS
414-955-0989
Shekar N Kurpad, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

Related Studies